CTOR vs LI · $105.2M cap vs P/E 24, rev $16.06B
Citius Oncology, Inc. (CTOR) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
CTOR currently screens at market cap $105.2M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the CTOR and LI stock pages for the full models.
Not investment advice.